SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure as investors react to a combination of disappointing quarterly delivery figures, J.P. Morgans analyst downgrade citing major downside risk, and growing community speculation that capital is rotating out of the stock in anticipation of the upcoming SpaceX IPO. Amidst a volatile geopolitical climate, discussions on the platform are dominated by debates over leadership, the company's long-term competitive moat in the EV and AI space, and highly active trading around the stock's technical support levels.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as investors debate the company's ability to overcome manufacturing hurdles at its Malaysia facility, specifically relating to laser dicing and production yields. While the community remains polarized between those viewing the stock as a distressed 'zombie' play and long-term believers citing institutional ownership and potential partnerships, high short interest and anticipation of upcoming purchase orders keep sentiment highly volatile.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubo is facing intense debate as investors weigh the company's long-term financial guidance against a sharp price decline following a recent reverse stock split. The community remains deeply polarized, with some bulls pointing to sports-streaming dominance as a reason to hold, while skeptical traders focus on persistent bearish momentum and management's silence as catalysts for further short-selling.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as investors cheer the company's strategic pivot into AI infrastructure and recent high-profile production orders for its ultra-high-power testing systems. The community is heavily focused on the company's role as a critical bottleneck gatekeeper for reliability in the hyperscale data center supply chain, fueling bullish sentiment around upcoming earnings and guidance.

“Buttcoin - The Next Bitcoin” is the memecoin version of Bitcoin. Launched on January 30, 2025, on Pump.fun, it’s a community-owned memecoin on Solana. The idea was inspired by a 4:20 minutes long YouTube video from 2013 called "The Next Bitcoin?" by James D. McMurray.

Buttcoin

Buttcoin is gaining attention as a long-standing meme project, with the community actively debating whether its 15-year history of mocking the crypto industry translates into lasting value or a satirical phenomenon. Supporters are pushing the asset as a nostalgic, culture-driven alternative to mainstream tokens, while others view the surrounding social media fervor as a cautionary example of speculative retail behavior.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is drawing heavy trader interest as the community debates whether recent volatility and price action represent a durable support level or a setup for further downside. Investors are actively discussing the impact of leverage decay, institutional algorithmic manipulation, and conflicting sentiment regarding the long-term viability of high-growth technology promises.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending as institutional investors and whales navigate heightened volatility, with intense community debate over recent ETF accumulation patterns, broader macro pressures, and the potential impact of ongoing market manipulation allegations. The stock remains a focal point for both bulls eyeing long-term adoption and bears focused on short-term price weakness and systemic risks.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending as investors actively debate its long-term potential as a supplier for the Co-Packaged Optics (CPO) market, with community discussions focused on its strategic integration into next-generation AI data center roadmaps. While shareholders remain divided over the company's historical management performance, recent news cycles highlighting its role in emerging optical component supply chains have reignited interest in its growth prospects.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is experiencing significant volatility as investors weigh a strong quarterly earnings beat and positive guidance against broader solar sector headwinds and concerns over upcoming debt obligations. The community remains deeply polarized, with some bulls highlighting the long-term potential of residential solar and battery storage in an AI-driven energy economy, while others express frustration over the stock's persistent downtrend, regulatory uncertainty, and aggressive short-selling activity.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Telix Pharmaceuticals Limited (NASDAQ:TLX) Receives Average Rating of "Moderate Buy" from Analysts

Telix Pharmaceuticals Limited (NASDAQ:TLX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine research firms that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold...

Telix Pharmaceuticals Eyes 2026 Revenue Near $970M, Highlights PSMA Imaging Growth and Phase III Catalysts

Telix Pharmaceuticals (NASDAQ:TLX) executives highlighted commercial momentum in prostate cancer imaging and outlined multiple clinical programs in oncology during an H.C. Wainwright discussion featuring CEO Chris Behrenbruch and CMO David Cade.

Company overview and 2026 revenue outlook
Behrenbruch...

What Powers BWXT's Strength in Nuclear Medicine Manufacturing?

BWX Technologies expands beyond defense, boosting nuclear medicine with isotopes, new capabilities and a growing role in cancer diagnostics and treatment.

Telix Pharmaceuticals (NASDAQ:TLX) Trading Up 6.6% - Here's What Happened

Telix Pharmaceuticals (NASDAQ:TLX) Shares Up 6.6% - Time to Buy...

Telix Pharmaceuticals (NASDAQ:TLX) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen lowered shares of Telix Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Sunday...

Portland Investment Counsel Inc. Takes $1.23 Million Position in Telix Pharmaceuticals Limited $TLX

Portland Investment Counsel Inc. purchased a new position in Telix Pharmaceuticals Limited (NASDAQ:TLX - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The...

Telix Pharmaceuticals Limited (NASDAQ:TLX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Telix Pharmaceuticals Limited (NASDAQ:TLX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine brokerages that are currently covering the stock, Marketbeat.com...

Telix Pharmaceuticals (NASDAQ:TLX) Upgraded at Wall Street Zen

Wall Street Zen raised Telix Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Saturday...

Telix Pharmaceuticals (NASDAQ:TLX) Stock Price Up 5.5% - Time to Buy?

Telix Pharmaceuticals (NASDAQ:TLX) Shares Up 5.5% - What's Next...

Telix Pharmaceuticals Highlights $1B Revenue Track, Pixclara Resubmission, PSMA Growth at Oppenheimer Conf.

Telix Pharmaceuticals (NASDAQ:TLX) outlined its commercial imaging franchise, regulatory plans for two radiodiagnostic candidates, and progress across a broad therapeutic radiopharmaceutical pipeline...

Telix Pharmaceuticals Limited. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals. The Product Development segment develops radiopharmaceutical products for commercialization. It focuses on cancer care, specifically in prostate, renal or kidney and glioblastoma or brain cancer. Its products include TLX250, TLX591, and TLX101. The company was founded by Andreas Kluge and Christian P. Behrenbruch in November 2015 and is headquartered in Melbourne, Australia.

Current Price	$9.07
Prev Close	$9.13
Open	$9.20
Dividend Yield	0.00%
50-Day Moving Average	$7.70
Beta	0.00
Avg. Volume	284,289.89
PE Ratio	-432.70

52-Week High	$20.00
52-Week Low	$6.28
Market Capitalization	$3.09B
EPS (Annual)	-$0.0211
Price to Book	7.45
Revenue Per Employee	N/A

TLX
Telix Pharmaceuticals Limited American Depositary Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TLX News

TLXTelix Pharmaceuticals Limited American Depositary Shares